Literature DB >> 9003686

The importance of antibiotic pharmacokinetics in critical illness.

D E Fry1.   

Abstract

Antibiotics are the most commonly used drugs in the surgical patient. Pharmacokinetics is the study of processes that result in the delivery of drugs to effector sites. Drug absorption, distribution, biotransformation, and excretion are the critical elements of drug delivery to effector sites. The biologic elimination half-life (t1/2) and the volume of distribution (Vd) are terms used to describe the active processes of pharmacokinetics; t1/2 and Vd are determined for antibiotics by employing healthy volunteers or minimally ill patients. From these data, dosing schedules for each antibiotic are determined. This article reviews the literature on the impact of critical illness and sepsis on antibiotic pharmacokinetics. The data identify that t1/2 may be reduced in the hyperdynamic states of stress and sepsis and that the Vd is expanded. These changes mean that currently accepted dosing regimens of antibiotics in critically ill patients are inadequate. Subtherapeutic antibiotic concentrations in these patients may account for treatment failures and may be of significance in the emergence of bacterial resistance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9003686     DOI: 10.1016/s0002-9610(96)00346-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  9 in total

Review 1.  Differential Paradigms in Animal Models of Sepsis.

Authors:  S Manoj Kumar Kingsley; B Vishnu Bhat
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

2.  Clinical scoring system for the prediction of target site penetration of antimicrobials in patients with sepsis.

Authors:  Barbara S Zeitlinger; Markus Zeitlinger; Irmgard Leitner; Markus Müller; Christian Joukhadar
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

3.  Population pharmacokinetics of arbekacin in burn patients.

Authors:  Jong Hyun Kim; Hyon-Oh Lah; Dong-Seok Yim
Journal:  Eur J Clin Pharmacol       Date:  2008-06       Impact factor: 2.953

4.  Cefepime dosing in the morbidly obese patient population.

Authors:  Barrie S Rich; Rebecca Keel; Vanessa P Ho; Harma Turbendian; Cheguevara I Afaneh; Gregory F Dakin; Alfons Pomp; David P Nicolau; Philip S Barie
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

Review 5.  Antibiotic dosing in critically ill patients with acute kidney injury.

Authors:  Rachel F Eyler; Bruce A Mueller
Journal:  Nat Rev Nephrol       Date:  2011-02-22       Impact factor: 28.314

Review 6.  Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.

Authors:  Federico Pea; Pierluigi Viale; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 7.  Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.

Authors:  Jason A Roberts; Jeffrey Lipman
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 8.  Therapeutic interventions in sepsis: current and anticipated pharmacological agents.

Authors:  Prashant Shukla; G Madhava Rao; Gitu Pandey; Shweta Sharma; Naresh Mittapelly; Ranjita Shegokar; Prabhat Ranjan Mishra
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

9.  Imipenem in burn patients: pharmacokinetic profile and PK/PD target attainment.

Authors:  David S Gomez; Cristina Sanches-Giraud; Carlindo V Silva; Amanda M Ribas Rosa Oliveira; Joao Manoel da Silva; Rolf Gemperli; Silvia R C J Santos
Journal:  J Antibiot (Tokyo)       Date:  2014-09-17       Impact factor: 2.649

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.